Skip to main content
Year archive

Sinco Pharmaceuticals Holdings Limited — 2026 filings

All 26 regulatory filings released by Sinco Pharmaceuticals Holdings Limited (6833) in 2026, sourced directly from the official regulator.

26 Filings
2026 Period
2026 filings (26)
Filing Released Lang
APPOINTMENT OF CHAIRMAN OF THE BOARD AND CHAIRMAN OF THE NOMINATION COMMITTEE
Board/Management Information
2026-05-22 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2026-05-22 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 15 MAY 2026
Declaration of Voting Results & Voting Rights Announcements
2026-05-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings
2026-05-06 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2026-04-30 English
(1) RESIGNATION OF CHAIRMAN OF THE BOARD, EXECUTIVE DIRECTOR, CHAIRMAN OF NOMINATION COMMITTEE AND AUTHORISED REPRESENTATIVE; (2) CHANGE OF AUTHORISED REPRESENTATIVE; AND (3) NON-COMPLIANCE WITH RULE
Board/Management Information
2026-04-30 English
Letter to Non-Registered Shareholders - Notice of Publication of 2025 Annual Report, Circular, Notice of Annual General Meeting, Proxy Form and Reply Form
Report Publication Announcement
2026-04-20 English
Letter to Registered Shareholders - Notice of Publication of 2025 Annual Report, Circular, Notice of Annual General Meeting, Proxy Form and Reply Form
Report Publication Announcement
2026-04-20 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2026-04-20 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2026-04-20 English
(1) PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; (2) RE-ELECTION OF DIRECTORS; (3) PROPOSED FINAL DIVIDEND; AND (4) NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2026-04-20 English
Environmental, Social and Governance Report 2025
Regulatory Filings
2026-04-20 English
Annual Report 2025
Regulatory Filings
2026-04-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
Regulatory Filings
2026-04-01 English
Final Dividend for the year ended 31 December 2025 (updated)
Notice of Dividend Amount
2026-03-27 English
Final Dividend for the year ended 31 December 2025
Notice of Dividend Amount
2026-03-26 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025
Annual Report FY 2025
2026-03-26 English
DATE OF BOARD MEETING
Report Publication Announcement
2026-03-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026
Regulatory Filings
2026-03-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026
Share Issue/Capital Change
2026-02-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2026
Regulatory Filings
2026-02-02 English
VOLUNTARY ANNOUNCEMENT - POSITIVE RESULTS FROM PHASE II TRIAL OF TQA3605 "CORE PROTEIN ALLOSTERIC MODULATOR" FOR CHRONIC HEPATITIS B
Regulatory Filings
2026-01-27 English
CHANGE OF COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
Board/Management Information
2026-01-13 English
SHARE TRANSACTION ACQUISITION OF 100% EQUITY INTEREST IN HYGIEIA INVOLVING THE ISSUE OF CONSIDERATION SHARES UNDER GENERAL MANDATE
M&A Activity
2026-01-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
Regulatory Filings
2026-01-05 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2025
Share Issue/Capital Change
2026-01-02 English